{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:18:57Z","timestamp":1792592337603,"version":"4.5.0"},"reference-count":175,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2021,6,24]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>Autoimmune liver diseases are chronic inflammatory hepatobiliary disorders that when classically defined encompass three distinctive clinical presentations; primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). Meaningful changes in disease epidemiology are reported, with increasing incidence and prevalence of AIH and PSC in Europe, and rising prevalence of PBC across Europe, North America and the Asia-Pacific region. However, there appears to be very significant global variation with contemporary incidence rates of disease per 100 000 ranging from 0.84 to 2.75 for PBC, 0.1 to 4.39 for PSC and 0.4 to 2.39 for AIH. Prevalence corresponds, and per 100 000 estimates for PBC range from 1.91 to 40.2, for PSC between 0.78 and 31.7 and for AIH from 4.8 to 42.9. Population-based studies and multicentre observational cohort series provide improved understanding of the clinical course that patients experience, highlighting variations in presenting phenotypes geographically and temporally. Collectively, while autoimmune liver diseases are rare, the clinical burden is disproportionately high relative to population incidence and prevalence. Age, sex and race also impact clinical outcomes, and patient morbidity and mortality are reflected by high need for gastroenterology, hepatology and organ transplant services.<\/jats:p>","DOI":"10.1136\/gutjnl-2020-322362","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T13:20:18Z","timestamp":1626355218000},"page":"1989-2003","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":238,"title":["Recent advances in clinical practice: epidemiology of autoimmune liver diseases"],"prefix":"10.1136","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4009-8087","authenticated-orcid":false,"given":"Palak J","family":"Trivedi","sequence":"first","affiliation":[{"name":"National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Centre, University of Birmingham College of Medical and Dental Sciences, Birmingham, Birmingham, UK"},{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK"},{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"},{"name":"Liver Unit, University Hospitals Birmingham National Health Service Foundation Trust Queen Elizabeth, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6736-2255","authenticated-orcid":false,"given":"Gideon M","family":"Hirschfield","sequence":"additional","affiliation":[{"name":"Toronto Centre for Liver Disease, Division of Gastroenterology and Hepatology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"2025112110194313000_70.10.1989.1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"2025112110194313000_70.10.1989.2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/a-1135-9306","article-title":"Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatment","volume":"58","author":"Sebode","year":"2020","journal-title":"Z Gastroenterol"},{"key":"2025112110194313000_70.10.1989.3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.13548","article-title":"Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977-2011","volume":"38","author":"S\u00f8rensen","year":"2018","journal-title":"Liver Int"},{"key":"2025112110194313000_70.10.1989.4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007116","article-title":"Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine"},{"key":"2025112110194313000_70.10.1989.5","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17093095","article-title":"Primary sclerosing cholangitis: burden of disease and mortality using data from the National rare diseases registry in Italy","volume":"17","author":"Carbone","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2025112110194313000_70.10.1989.6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47890-2","article-title":"Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort","volume":"9","author":"Marschall","year":"2019","journal-title":"Sci Rep"},{"key":"2025112110194313000_70.10.1989.7","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.29717","article-title":"Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history","volume":"67","author":"Murillo Perez","year":"2018","journal-title":"Hepatology"},{"key":"2025112110194313000_70.10.1989.8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/apt.15060","article-title":"Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades","volume":"49","author":"Harms","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112110194313000_70.10.1989.9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.04.010","article-title":"Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis","author":"Tanaka","year":"2021","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-5-581"},{"key":"2025112110194313000_70.10.1989.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.02.038"},{"key":"2025112110194313000_70.10.1989.12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313681"},{"key":"2025112110194313000_70.10.1989.13","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22131"},{"key":"2025112110194313000_70.10.1989.14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21685"},{"key":"2025112110194313000_70.10.1989.15","doi-asserted-by":"crossref","first-page":"100074","DOI":"10.1016\/j.jtauto.2020.100074","article-title":"Igg4-Related disease: changing epidemiology and new thoughts on a multisystem disease","volume":"4","author":"Floreani","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"2025112110194313000_70.10.1989.16","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jgh.15329","article-title":"Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis","volume":"36","author":"Lv","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/937150","article-title":"Twelve-Year-Old girl with primary biliary cirrhosis","volume":"2012","author":"Kitic","year":"2012","journal-title":"Case Rep Pediatr"},{"key":"2025112110194313000_70.10.1989.18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/apt.13448","article-title":"Population-based epidemiology of primary biliary cirrhosis in South Korea","volume":"43","author":"Kim","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112110194313000_70.10.1989.19","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt308"},{"key":"2025112110194313000_70.10.1989.20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/hepr.13342","article-title":"Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan","volume":"49","author":"Tanaka","year":"2019","journal-title":"Hepatol Res"},{"key":"2025112110194313000_70.10.1989.21","doi-asserted-by":"crossref","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci Rep"},{"key":"2025112110194313000_70.10.1989.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2003.07.011"},{"key":"2025112110194313000_70.10.1989.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01103.x"},{"key":"2025112110194313000_70.10.1989.24","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"2025112110194313000_70.10.1989.25","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"Lancet"},{"key":"2025112110194313000_70.10.1989.26","doi-asserted-by":"crossref","first-page":"46273","DOI":"10.18632\/oncotarget.10090","article-title":"National incidence of autoimmune liver diseases and its relationship with the human development index","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"key":"2025112110194313000_70.10.1989.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.02.017"},{"key":"2025112110194313000_70.10.1989.28","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850166284"},{"key":"2025112110194313000_70.10.1989.29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"2025112110194313000_70.10.1989.30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23678"},{"key":"2025112110194313000_70.10.1989.31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.04.052"},{"key":"2025112110194313000_70.10.1989.32","first-page":"4517","article-title":"Incidence and prevalence of autoimmune liver diseases","volume":"118","author":"Berdal","year":"1998","journal-title":"Tidsskr Den Nor Laegeforening Tidsskr Prakt Med Ny Raekke"},{"key":"2025112110194313000_70.10.1989.33","first-page":"371","article-title":"[Primary sclerosing cholangitis in Iceland 1992-2012]","volume":"105","author":"Gudnason","year":"2019","journal-title":"Laeknabladid"},{"key":"2025112110194313000_70.10.1989.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(94)80240-8"},{"key":"2025112110194313000_70.10.1989.35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26565"},{"key":"2025112110194313000_70.10.1989.36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","volume":"19","author":"Lamba","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.10.025"},{"key":"2025112110194313000_70.10.1989.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"2025112110194313000_70.10.1989.39","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/hep.30479","article-title":"Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system","volume":"69","author":"Goode","year":"2019","journal-title":"Hepatology"},{"key":"2025112110194313000_70.10.1989.40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26454"},{"key":"2025112110194313000_70.10.1989.41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gr\u00f8nb\u00e6k","year":"2014","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.42","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.dld.2019.01.015","article-title":"Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: a nationwide register-based cohort study in Finland","volume":"51","author":"Puustinen","year":"2019","journal-title":"Dig Liver Dis"},{"key":"2025112110194313000_70.10.1989.43","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14480"},{"key":"2025112110194313000_70.10.1989.44","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.946083"},{"key":"2025112110194313000_70.10.1989.45","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2025112110194313000_70.10.1989.46","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.01.029","article-title":"The epidemiology of UK autoimmune liver disease varies with geographic latitude","author":"Webb","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.47","doi-asserted-by":"crossref","first-page":"n\/a","DOI":"10.1111\/1751-2980.12085","article-title":"Autoimmune hepatitis in southern Israel: a 15-year multicenter study","volume":"14","author":"Delgado","year":"2013","journal-title":"J Dig Dis"},{"key":"2025112110194313000_70.10.1989.48","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1007\/s10620-005-9068-y","article-title":"Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International autoimmune hepatitis group","volume":"51","author":"Koay","year":"2006","journal-title":"Dig Dis Sci"},{"key":"2025112110194313000_70.10.1989.49","doi-asserted-by":"publisher","DOI":"10.1157\/13059351"},{"key":"2025112110194313000_70.10.1989.50","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"2025112110194313000_70.10.1989.51","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the bologna experience","volume":"50","author":"Muratori","year":"2009","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/cld.797","article-title":"Long\u2010Term outcomes of autoimmune hepatitis","volume":"14","author":"Gleeson","year":"2019","journal-title":"Clinical Liver Disease"},{"key":"2025112110194313000_70.10.1989.53","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(20)31043-6","article-title":"Projection of liver transplant activity per indication in France and United Kingdom","volume":"73","author":"Connolly","year":"2020","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2017.09.062","article-title":"Twenty-Year comparative analysis of patients with autoimmune liver diseases on transplant Waitlists","volume":"16","author":"Webb","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-Term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.56","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25739","article-title":"Longterm survival after liver transplantation for autoimmune hepatitis: results from the European liver transplant registry","volume":"26","author":"Heinemann","year":"2020","journal-title":"Liver Transpl"},{"key":"2025112110194313000_70.10.1989.57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"key":"2025112110194313000_70.10.1989.58","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112110194313000_70.10.1989.59","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.60","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s12072-011-9329-0","article-title":"Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: a population-based study","volume":"6","author":"Ngu","year":"2012","journal-title":"Hepatol Int"},{"key":"2025112110194313000_70.10.1989.61","unstructured":"Net migration data. Available: https:\/\/data.worldbank.org\/indicator\/SM.POP.NETM?name_desc=false [Accessed 20 Dec 2020]."},{"key":"2025112110194313000_70.10.1989.62","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/00365521.2015.1036359","article-title":"Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013","volume":"50","author":"Fosby","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"2025112110194313000_70.10.1989.63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182391","article-title":"Population-Based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"2025112110194313000_70.10.1989.64","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/hepr.12639","article-title":"Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan","volume":"46","author":"Yoshizawa","year":"2016","journal-title":"Hepatol Res"},{"key":"2025112110194313000_70.10.1989.65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.06019.x"},{"key":"2025112110194313000_70.10.1989.66","article-title":"Epidemiology of autoimmune hepatitis (AIH) in the United States between 2014 and 2019: a population-based national study","author":"Tunio","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"2025112110194313000_70.10.1989.67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06384.x"},{"key":"2025112110194313000_70.10.1989.68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cld.2015.08.002","article-title":"The Immunogenetics of autoimmune cholestasis","volume":"20","author":"Trivedi","year":"2016","journal-title":"Clin Liver Dis"},{"key":"2025112110194313000_70.10.1989.69","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.03.016"},{"key":"2025112110194313000_70.10.1989.71","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1155\/2005\/203028","article-title":"Characteristics of primary biliary cirrhosis in British Columbia\u2019s first nations population","volume":"19","author":"Arbour","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"2025112110194313000_70.10.1989.72","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.05.005"},{"key":"2025112110194313000_70.10.1989.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.02.019"},{"key":"2025112110194313000_70.10.1989.74","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.04.064"},{"key":"2025112110194313000_70.10.1989.75","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.6.927"},{"key":"2025112110194313000_70.10.1989.76","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2018.05.035","article-title":"Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study","volume":"69","author":"Gr\u00f8nb\u00e6k","year":"2018","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.77","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-020-06490-1","article-title":"Differences between familial and sporadic celiac disease","volume":"66","author":"Airaksinen","year":"2021","journal-title":"Dig Dis Sci"},{"key":"2025112110194313000_70.10.1989.78","doi-asserted-by":"crossref","first-page":"100058","DOI":"10.1016\/j.jtauto.2020.100058","article-title":"Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden","volume":"3","author":"Thomsen","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"2025112110194313000_70.10.1989.79","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313598"},{"key":"2025112110194313000_70.10.1989.80","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"2025112110194313000_70.10.1989.81","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31893","article-title":"HLA profile predicts severity of autoimmune liver disease in children of European ancestry","author":"Ma","year":"2021","journal-title":"Hepatology"},{"key":"2025112110194313000_70.10.1989.82","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/gene.2014.76","article-title":"The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk","volume":"16","author":"Tang","year":"2015","journal-title":"Genes Immun"},{"key":"2025112110194313000_70.10.1989.83","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.119.044434"},{"key":"2025112110194313000_70.10.1989.84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.85","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20907"},{"key":"2025112110194313000_70.10.1989.86","doi-asserted-by":"crossref","first-page":"100202","DOI":"10.1016\/j.jhepr.2020.100202","article-title":"Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis","volume":"3","author":"Dyson","year":"2021","journal-title":"JHEP Rep"},{"key":"2025112110194313000_70.10.1989.87","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13154"},{"key":"2025112110194313000_70.10.1989.88","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613055"},{"key":"2025112110194313000_70.10.1989.89","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613056"},{"key":"2025112110194313000_70.10.1989.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.09.024"},{"key":"2025112110194313000_70.10.1989.91","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.136"},{"key":"2025112110194313000_70.10.1989.92","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4269\/ajtmh.2007.76.972","article-title":"An inverse relationship between autoimmune liver diseases and Strongyloides stercoralis infection","volume":"76","author":"Aoyama","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"2025112110194313000_70.10.1989.93","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/liv.14153","article-title":"The gut microbial influence on cholestatic liver disease","volume":"39","author":"Kummen","year":"2019","journal-title":"Liver Int"},{"key":"2025112110194313000_70.10.1989.94","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apt.15754","article-title":"A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis","volume":"51","author":"Liwinski","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112110194313000_70.10.1989.95","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3745"},{"key":"2025112110194313000_70.10.1989.96","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","article-title":"Cellular and molecular mechanisms of autoimmune hepatitis","volume":"13","author":"Webb","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"2025112110194313000_70.10.1989.97","doi-asserted-by":"crossref","DOI":"10.1186\/1752-1947-4-311","article-title":"Autoimmune hepatitis triggered by nitrofurantoin: a case series","volume":"4","author":"Appleyard","year":"2010","journal-title":"J Med Case Rep"},{"key":"2025112110194313000_70.10.1989.98","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bmj.312.7024.169","article-title":"Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome","volume":"312","author":"Gough","year":"1996","journal-title":"BMJ"},{"key":"2025112110194313000_70.10.1989.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.01.033"},{"key":"2025112110194313000_70.10.1989.100","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jhep.2021.02.006","article-title":"Primary biliary cholangitis associated with SARS-CoV-2 infection","volume":"74","author":"Bartoli","year":"2021","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.101","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril","year":"2021","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.102","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14944","article-title":"Environmental risk factors are associated with autoimmune hepatitis","author":"Lammert","year":"2021","journal-title":"Liver Int"},{"key":"2025112110194313000_70.10.1989.103","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.029"},{"key":"2025112110194313000_70.10.1989.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.09.009"},{"key":"2025112110194313000_70.10.1989.105","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/liv.13724","article-title":"Diagnosis, presentation and initial severity of autoimmune hepatitis (AIH) in patients attending 28 hospitals in the UK","volume":"38","author":"Gordon","year":"2018","journal-title":"Liver Int"},{"key":"2025112110194313000_70.10.1989.106","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)04410-8"},{"key":"2025112110194313000_70.10.1989.107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2019.01.005","article-title":"Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: is alkaline phosphatase truly a surrogate marker?","volume":"99","author":"Sun","year":"2019","journal-title":"J Autoimmun"},{"key":"2025112110194313000_70.10.1989.108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102578","article-title":"Primary biliary cholangitis with normal alkaline phosphatase: a neglected clinical entity challenging current guidelines","volume":"116","author":"Terziroli Beretta-Piccoli","year":"2021","journal-title":"J Autoimmun"},{"key":"2025112110194313000_70.10.1989.109","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-Scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"key":"2025112110194313000_70.10.1989.110","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/liv.13143","article-title":"Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up","volume":"36","author":"Gulamhusein","year":"2016","journal-title":"Liver Int"},{"key":"2025112110194313000_70.10.1989.111","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/liv.14645","article-title":"Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis","volume":"40","author":"Culver","year":"2020","journal-title":"Liver Int"},{"key":"2025112110194313000_70.10.1989.112","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cgh.2015.07.017","article-title":"Features and progression of asymptomatic autoimmune hepatitis in Italy","volume":"14","author":"Muratori","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.113","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ajg.2015.139","article-title":"Long-Term prognostic significance of persisting histological activity despite biochemical remission in autoimmune hepatitis","volume":"110","author":"Dhaliwal","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2025112110194313000_70.10.1989.114","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.12.005"},{"key":"2025112110194313000_70.10.1989.115","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cgh.2018.12.028","article-title":"Effects of age and sex of response to ursodeoxycholic acid and Transplant-free survival in patients with primary biliary cholangitis","volume":"17","author":"Cheung","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.116","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/hep.30174","article-title":"Primary biliary cholangitis in Medicare population: the impact on mortality and resource use","volume":"69","author":"Sayiner","year":"2019","journal-title":"Hepatology"},{"key":"2025112110194313000_70.10.1989.117","doi-asserted-by":"crossref","first-page":"262","DOI":"10.14309\/ajg.0000000000000512","article-title":"Ursodeoxycholic acid treatment preferentially improves overall survival among African Americans with primary biliary cholangitis","volume":"115","author":"Gordon","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"2025112110194313000_70.10.1989.118","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"key":"2025112110194313000_70.10.1989.119","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cgh.2017.10.028","article-title":"Primary sclerosing cholangitis is not rare among blacks in a multicenter North American Consortium","volume":"16","author":"Goldberg","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.120","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.22161","article-title":"Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations","volume":"16","author":"Bowlus","year":"2010","journal-title":"Liver Transpl"},{"key":"2025112110194313000_70.10.1989.121","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.065"},{"key":"2025112110194313000_70.10.1989.122","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00535-016-1267-0","article-title":"Autoimmune hepatitis in Japan: trends in a nationwide survey","volume":"52","author":"Takahashi","year":"2017","journal-title":"J Gastroenterol"},{"key":"2025112110194313000_70.10.1989.123","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24743"},{"key":"2025112110194313000_70.10.1989.124","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/apt.13210","article-title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","volume":"41","author":"Muratori","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112110194313000_70.10.1989.125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.04.007"},{"key":"2025112110194313000_70.10.1989.126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.08.013"},{"key":"2025112110194313000_70.10.1989.127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.05272.x"},{"key":"2025112110194313000_70.10.1989.128","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21884"},{"key":"2025112110194313000_70.10.1989.129","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.5.713"},{"key":"2025112110194313000_70.10.1989.130","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2018.11.028","article-title":"Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis","volume":"17","author":"de Boer","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01088.x"},{"key":"2025112110194313000_70.10.1989.132","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2036.2006.03013.x","article-title":"Clinical features of Japanese male patients with type 1 autoimmune hepatitis","volume":"24","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112110194313000_70.10.1989.133","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71296-0","article-title":"Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan","volume":"10","author":"Takahashi","year":"2020","journal-title":"Sci Rep"},{"key":"2025112110194313000_70.10.1989.134","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00182-4"},{"key":"2025112110194313000_70.10.1989.135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transpl"},{"key":"2025112110194313000_70.10.1989.136","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2017.06.027","article-title":"Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis","volume":"67","author":"Trivedi","year":"2017","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.137","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112110194313000_70.10.1989.138","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3951"},{"key":"2025112110194313000_70.10.1989.139","unstructured":"Organ . Donation and transplantation activity report 2017\/18. NHSBT, 2018."},{"key":"2025112110194313000_70.10.1989.140","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.cgh.2018.04.047","article-title":"Characteristics and outcomes reported by patients with primary sclerosing cholangitis through an online registry","volume":"17","author":"Kuo","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112110194313000_70.10.1989.141","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1016\/S0618-8278(19)30812-6","article-title":"FRI-062-Identifying research priorities in primary sclerosing cholangitis: Driving clinically meaningful change from the patients\u2019 perspective","volume":"70","author":"Walmsley","year":"2019","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.142","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21472"},{"key":"2025112110194313000_70.10.1989.143","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/liv.13236","article-title":"Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int"},{"key":"2025112110194313000_70.10.1989.144","doi-asserted-by":"publisher","DOI":"10.1016\/j.hepres.2004.03.006"},{"key":"2025112110194313000_70.10.1989.145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/liv.13963","article-title":"Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: a Danish nationwide cohort study","volume":"39","author":"Gr\u00f8nbaek","year":"2019","journal-title":"Liver Int"},{"key":"2025112110194313000_70.10.1989.146","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2009.02003.x"},{"key":"2025112110194313000_70.10.1989.147","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.20894"},{"key":"2025112110194313000_70.10.1989.148","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transpl"},{"key":"2025112110194313000_70.10.1989.149","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"2025112110194313000_70.10.1989.150","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20123"},{"key":"2025112110194313000_70.10.1989.151","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-Term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"key":"2025112110194313000_70.10.1989.152","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-Term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"key":"2025112110194313000_70.10.1989.153","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"key":"2025112110194313000_70.10.1989.154","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J Hepatol"},{"key":"2025112110194313000_70.10.1989.155","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-Term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"Am J Transplant"},{"key":"2025112110194313000_70.10.1989.156","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep4.1037","article-title":"Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: a Japanese multicenter retrospective study","volume":"1","author":"Kogiso","year":"2017","journal-title":"Hepatol Commun"},{"key":"2025112110194313000_70.10.1989.157","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199705000-00004"},{"key":"2025112110194313000_70.10.1989.158","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199811270-00006"},{"key":"2025112110194313000_70.10.1989.159","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290427"},{"key":"2025112110194313000_70.10.1989.160","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transpl"},{"key":"2025112110194313000_70.10.1989.161","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"key":"2025112110194313000_70.10.1989.162","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21260"},{"key":"2025112110194313000_70.10.1989.163","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21313"},{"key":"2025112110194313000_70.10.1989.164","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21679"},{"key":"2025112110194313000_70.10.1989.165","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"key":"2025112110194313000_70.10.1989.166","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation-a single-centre experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"2025112110194313000_70.10.1989.167","first-page":"16","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation - The Hungarian experience","volume":"6","author":"Gelley","year":"2014","journal-title":"Interv Med Appl Sci"},{"key":"2025112110194313000_70.10.1989.168","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/lt.24496","article-title":"Recurrent primary sclerosing cholangitis in the Adult-to-Adult living donor liver transplantation cohort study: comparison of risk factors between living and deceased donor recipients","volume":"22","author":"Gordon","year":"2016","journal-title":"Liver Transpl"},{"key":"2025112110194313000_70.10.1989.169","doi-asserted-by":"crossref","unstructured":"Lindstr\u00f6m L , J\u00f8rgensen KK , Boberg KM . Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic multicentre study. Scand J Gastroenterol 2018:1\u20138.","DOI":"10.1080\/00365521.2017.1421705"},{"key":"2025112110194313000_70.10.1989.170","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"2025112110194313000_70.10.1989.171","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.16666"},{"key":"2025112110194313000_70.10.1989.172","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21796"},{"key":"2025112110194313000_70.10.1989.173","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199907270-00016"},{"key":"2025112110194313000_70.10.1989.174","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12936","article-title":"Histologic surveillance after liver transplantation due to autoimmune hepatitis","volume":"31","author":"Puustinen","year":"2017","journal-title":"Clin Transplant"},{"key":"2025112110194313000_70.10.1989.175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transpl"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2020-322362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:20:10Z","timestamp":1763749210000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2020-322362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":175,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,9,8]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/gutjnl-2020-322362"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2020-322362","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]}}}